Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2010 Oct 5;119(2):272–278. doi: 10.1289/ehp.1002169

Prenatal Organochlorine Compound Exposure, Rapid Weight Gain, and Overweight in Infancy

Michelle A Mendez 1,2,3,, Raquel Garcia-Esteban 1,2,3, Mónica Guxens 1,2,3, Martine Vrijheid 1,2,3, Manolis Kogevinas 1,2,3,4, Fernando Goñi 3,5, Silvia Fochs 1,2,3, Jordi Sunyer 1,2,3,6
PMCID: PMC3040617  PMID: 20923745

Abstract

Background

Although it has been hypothesized that fetal exposure to endocrine-disrupting chemicals may increase obesity risk, empirical data are limited, and it is uncertain how early in life any effects may begin.

Objectives

We explored whether prenatal exposure to several organochlorine compounds (OCs) is associated with rapid growth in the first 6 months of life and body mass index (BMI) later in infancy.

Methods

Data come from the INMA (Infancia y Medio-Ambiente) Child and Environment birth cohort in Spain, which recruited 657 women in early pregnancy. Rapid growth during the first 6 months was defined as a change in weight-for-age z-scores > 0.67, and elevated BMI at 14 months, as a z-score ≥ the 85th percentile. Generalized linear models were used to estimate the risk of rapid growth or elevated BMI associated with 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (DDE), hexachlorobenzene, β-hexachlorohexane, and polychlorinated biphenyls in first-trimester maternal serum.

Results

After multivariable adjustment including other OCs, DDE exposure above the first quartile was associated with doubling of the risk of rapid growth among children of normal-weight (BMI < 25 kg/m2), but not overweight, mothers. DDE was also associated with elevated BMI at 14 months (relative risk per unit increase in log DDE = 1.50; 95% confidence interval, 1.11–2.03). Other OCs were not associated with rapid growth or elevated BMI after adjustment.

Conclusions

In this study we found prenatal DDE exposure to be associated with rapid weight gain in the first 6 months and elevated BMI later in infancy, among infants of normal-weight mothers. More research exploring the potential role of chemical exposures in early-onset obesity is needed.

Keywords: β-hexachlorohexane, body mass index, dichlorodiphenyldichloroethylene, hexachlorobenzene, infant, obesity, polychlorinated biphenyls, prenatal, weight gain


The past few decades have seen dramatic increases in obesity prevalence in all age groups worldwide (Kelly et al. 2008; Wang and Lobstein 2006). There is substantial evidence that obesity risk may begin very early in life; > 40 studies have documented rapid weight gain in the first few months after birth to be associated with obesity later in life (Akaboshi et al. 2008; Blair et al. 2007; Botton et al. 2008; Chomtho et al. 2009; Demerath et al. 2009; Dubois and Girard 2006; Durmuş et al. 2010; Ekelund et al. 2006; Eriksson et al. 2008; Goodell et al. 2009; Hitze et al. 2010; Kain et al. 2009; Karaolis-Danckert et al. 2006; Lamb et al. 2010; Ong and Loos 2006; Ong et al. 2009; Taveras et al. 2009; Toschke et al. 2004) or related metabolic disorders (Cournil et al. 2009; EURODIAB Substudy 2 Study Group 2002; Harder et al. 2009; Huxley et al. 2000; Law et al. 2002; Leunissen et al. 2009). Although feeding practices likely play a role (Koletzko et al. 2009; Worobey et al. 2009), there is considerable uncertainty regarding other factors that may program this rapid infant growth.

There is emerging interest in the possibility that perinatal exposure to certain xenobiotic chemicals may be obesogenic (Grün and Blumberg 2009; Heindel and vom Saal 2009). Substantial evidence suggests that gestational tobacco exposure is related to excess weight gain and later obesity (Mendez et al. 2008; Oken et al. 2008). Laboratory studies suggest that prenatal exposure to some endocrine-disrupting compounds (EDCs) may also promote obesity. For example, despite similar dietary intakes, excess postnatal weight gain has been observed in mice exposed perinatally to bisphenol A (BPA) or organotins (Grün et al. 2006; Rubin et al. 2001; Somm et al. 2009). However, few EDCs have been examined in laboratory studies thus far. More important, there are limited empirical data linking such exposures to obesity in humans (Elobeid and Allison 2008). One recent study (Smink et al. 2008) reported an association between obesity at 6.5 years of age and prenatal hexachlorobenzene (HCB) exposure, and two reported fetal exposure to 2,2-bis(p-chlorophenyl)-1,1-dichloroethylene (DDE) to be associated with higher body mass index (BMI) at 3 years of age (Verhulst et al. 2009) or in adulthood (Karmaus et al. 2009). It remains uncertain whether such exposures in humans may program rapid weight gain beginning in infancy.

In this study we examined the relationship between rapid weight gain in the first 6 months of life and prenatal exposure to several organochlorine compounds (OCs) with endocrine-disrupting properties, including DDE and HCB. Because maternal weight status may modify children’s risk of obesity, perhaps due to differential feeding practices (Buyken et al. 2008) or higher OC concentrations among those with higher BMIs (Jakszyn et al. 2009), we examined possible effect modification by prepregnancy overweight/obesity (hereafter overweight) a priori. We also examine how rapid early weight gain and OC exposure relate to BMI status attained in the second year of life.

Materials and Methods

Data come from the Environment and Childhood Project [Infancia y Medio-Ambiente (INMA)] in Sabadell (Catalonia, Spain), a population-based birth cohort that enrolled 657 women in 2004–2006, during the first trimester of pregnancy (Ribas-Fitó et al. 2006). Women were recruited from public health centers during their first ultrasound visit (mean ± SD, 13.5 ± 1.7 weeks’ gestation); 99.5% of Spaniards have public health insurance, and an estimated 70–90% of women use public health services during pregnancy (Regidor et al. 2008). The participation rate was 60%. Questionnaires were administered by trained interviewers during the first and third trimester, at delivery, and at 6 and 14 months after birth to assess health and feeding behaviors, health status, sociodemographic characteristics, reproductive history, and other factors. Maternal blood was collected at recruitment. Birth outcomes were available for 616 women (94%), including 599 term births (≥ 37 weeks’ gestation) eligible for this analysis. Of these, 518 (86%) had data on infant growth, OCs, and key covariates and were included in the analysis sample. Ethical approval was obtained from the Clinical Research Ethical Committee of the Municipal Institute of Health Care, and informed consent was obtained from all subjects.

Infant anthropometry

Infant weight (nearest gram) and length (nearest 0.1 cm) were measured at birth and at 14 months by trained staff in using standard protocols (Lohman 1988). Infants below the 10th percentile of a Spanish reference were classified as small for gestational age (SGA) (Carrascosa et al. 2004). Repeated measures of infant weight throughout the first 6 months were abstracted from medical records. Weight gain from birth to 6 months was estimated in two ways. First, weight measures were used to construct sex-specific growth curves using mixed models with random intercept and slope after transformations based on fractional polynomials (Royston 1995). These curves were used to estimate weight at 6 months of age for infants not measured within ±14 days of their exact 6-month anniversary (16.2% of the sample). The correlation between measured and predicted 6-month weight was 0.96; restricting the analysis to infants with measured weights yielded very similar results (data not shown). Second, weight measured within ±1 month of the 6-month anniversary was used to estimate average daily weight gain through 6 months (95.8% of the analysis sample). Defining rapid growth as the highest tertile of average daily weight gain yielded very similar results (data not shown).

To define rapid growth, weight at birth and at 6 months of age was standardized based on the World Health Organization referent (de Onis et al. 2009). Rapid growth was defined as a z-score change of > 0.67 between birth and 6 months of age, and slow growth was defined as a z-score change of < 0.67 (Monteiro and Victora 2005). Results were consistent with defining rapid growth using internal standardization of the sample or the U.S. Centers for Disease Control and Prevention referent (Kuczmarski et al. 2002) (data not shown). Additionally, to estimate effects of rapid early growth and OC exposure on later nutritional status, we estimated associations with BMI-for-age z-scores at 14 months of age. BMI z-scores ≥ 1.44, corresponding to the 85th percentile typically used to define child overweight, were defined as elevated. Consistent results were obtained classifying 14-month weight status using the U.S. referent and weight-for-length z-scores (data not shown).

OC exposures

Maternal first-trimester serum levels of DDE, HCB, DDT [2,2-bis(p-chlorophenyl)-1,1,1-trichloroethane], β-hexachlorohexane (βHCH), and polychlorinated biphenyl (PCB) congeners 118, 138, 153, and 180 were measured by the Public Health Laboratory of the Basque government, using methods described elsewhere (Goñi et al. 2007). Because 99% of the sample had DDT levels below the limits of detection (LODs), this OC was excluded from the analysis. All subjects had detectable levels of DDE. For the remaining OCs, with up to approximately 10% below the LODs, levels were adjusted for lipids as prescribed by Phillips et al. (1989). Values below the LOD were imputed as LOD/2.

Other variables

Maternal age, parity, education level, prepregnancy weight, country of origin, and occupation, along with paternal height, weight, and occupation, were reported by mothers at recruitment. Occupation data were used to assess social class (Instituto Nacional de Estadística 1994). Maternal height (nearest 0.5 cm) was used to calculate prepregnancy BMI (weight in kilograms/height in square meters) to classify women as normal weight, overweight (BMI ≥ 25 kg/m2), or obese (≥ 30 kg/m2). Weight gains throughout pregnancy from prenatal visit records were used to validate prepregnancy weight and to estimate gestational weight gain adequacy (Institute of Medicine 2009). Information on tobacco use throughout pregnancy was self-reported in the first and third trimesters, child sex was recorded at birth, and breast-feeding duration was reported in postnatal questionnaires. All analyses of rapid growth were conducted in the sample with complete data for the main exposure, outcome, and covariates (n = 518); analyses of BMI at 14 months had slightly fewer observations because of missing values for this variable (n = 502). Within the analysis sample with complete exposure and outcome data, there were few additional missing values for covariates (n = 17 and n = 16, respectively, for analyses of rapid growth and BMI at 14 months).

Statistical analysis

Characteristics of rapid versus average/slow growers, including maternal OC levels and infant anthropometric measures, were described using means ± SD or proportions, with chi-square, analysis of variance, Student’s t-test, or Wilcoxon–Mann–Whitney tests applied as appropriate to assess statistical significance (p < 0.05 considered significant for main effects). Because maternal weight status was found to modify the effect of OC exposures on rapid growth (p < 0.10 used to define significance for interactions), OC levels were also described separately among normal-weight versus overweight women. Because distributions were skewed, geometric means were used to describe levels of OCs and significance assessed using Wilcoxon–Mann–Whitney tests on log-transformed data. Relationships among OCs were assessed using Spearman’s correlations and log-transformed data.

Generalized linear models (GLMs) for binary outcomes were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for associations between increasing levels of each OC and rapid early growth (Zou 2004). To assess the linearity of relationships, generalized additive models were used to examine the shape of the dose–response relationship adjusted for relevant confounders (Hastie and Tibshirani 1995). When relationships were nonlinear, OC quartiles were used; log-transformed continuous variables were used for linear relationships. GLMs were also used to assess how both rapid early growth and prenatal OCs—separately as well as adjusting simultaneously—related to the risk of elevated BMI at 14 months.

Maternal characteristics (age, education, social class, parity, prepregnancy weight status, gestational weight gain, smoking during pregnancy, weeks of gestation at blood sampling, triglycerides, cholesterol) and other potential influences on postnatal growth, including child’s sex, gestational age at birth and SGA status, paternal height and weight, and breast-feeding duration, were considered as potential confounders of associations between prenatal OCs and infant growth. Covariates retained in the final models included infants’ exact age at measurement and variables that resulted in a change in estimate ≥ 10%.

In supplementary analyses, we confirmed that excluding SGA (n = 28) or low-birth-weight (n = 15) infants, among whom catch-up growth may be normative, did not meaningfully change results. Results for individual PCB congeners, similar to those for the sum of PCBs, are not shown. Excluding women born outside Spain (n = 50), who may differ in terms of OC exposures and infant care practices, and excluding nonwhite (n = 13) or underweight (BMI < 18; n = 30) mothers at the start of pregnancy also had no meaningful influence on results (data not shown).We examined whether child sex modified effects of OCs on growth; interactions did not reach significance (p > 0.10). Finally, we confirmed that associations did not change when meaningfully restricting the referent to average growers (n = 276, 53.28% of the sample) rather than average/slow growers (data not shown). All analyses used STATA, version 10.1 (StataCorp LP, College Station, TX, USA).

Results

Though rapid growers weighed less at birth (mean difference, 293 g), by 6 months of age these infants were significantly heavier than were average/slow growers (891 g) (Table 1). Rapid growers remained taller and heavier at 14 months.

Table 1.

Characteristics of rapid, average, and slow growers.

Characteristic Average/slow growers (n = 393) Rapid growers (n = 125) p-Valuea
Male sex 201 (51.2) 64 (51.2%) 0.991

Birth characteristics

 Birth weight (kg) 3.34 ± 0.02 3.04 ± 0.04 < 0.001
 Birth weight z-score 0.069 ± 0.039 −0.574 ± 0.076 < 0.001
 Birth length (cm) 49.69 ± 0.09 48.98 ± 0.16 < 0.001
 Gestational age (weeks) 39.90 ± 0.06 39.53 ± 0.10 0.003
 SGA 17 (4.34) 21 (16.80) < 0.001
 Low birth weight (< 2,500 g) 3 (0.76) 12 (9.60) < 0.001

Infant growth at 6 and 14 months

 Weight at 6 months (kg) 7.42 ± 0.04 8.29 ± 0.08 < 0.001
 Weight z-score at 6 months −0.28 ± 0.80 0.68 ± 0.83 < 0.001
 Weight at 14 months (kg) 10.07 ± 0.05 11.12 ± 0.12 < 0.001
 Length at 14 months (cm) 77.37 ± 0.15 78.75 ± 0.24 < 0.001
 BMI at 14 months (kg/m2) 16.64 ± 1.33 18.26 ± 1.51 < 0.001
 Weight z-score (14 months) 0.12 ± 0.85 0.96 ± 0.99 < 0.001
 Length z-score (14 months) −0.20 ± 1.04 0.33 ± 0.96 < 0.001
 BMI z-score (14 months) 0.34 ± 0.82 1.06 ± 0.95 < 0.001

Parental characteristics

 Maternal age (years) 31.78 ± 0.21 31.63 ± 0.41 0.983
 Maternal height (m) 1.62 ± 0.00 1.63 ± 0.01 0.592
 Maternal parity (firstborn) 216 (54.96) 76 (60.80) 0.252
 Maternal overweight/obesity 112 (28.5) 32 (25.6) 0.529
 Mother born outside Spain 38 (9.74) 12 (9.76) 0.997
 Maternal education
  Primary or less 94 (23.98) 42 (33.87)
  Secondary 166 (42.35) 48 (38.71)
  University 132 (33.67) 34 (27.42) 0.084
 Manual occupation, motherb 181 (46.1) 66 (52.8) 0.189
 Paternal height (m) 1.76 ± 0.004 1.77 ± 0.007 0.257
 Paternal overweight/obesity 209 (53.7) 71 (57.7) 0.438
 Manual occupation, father 206 (56.0) 73 (61.3) 0.304

Values are mean ± SD or n (%). Data are for the complete analysis data set; missing values for individual covariates ranged from 2 to 14 observations, with n = 17 observations lost due to missing values for all covariates combined. There was no significant difference in the proportion missing among average/slow versus rapid growers (p-values, two-sample test for proportions > 0.3). World Health Organization data (de Onis et al. 2009) were used to derive z-scores.

a

t-Test (for normally distributed) or Wilcoxon–Mann–Whitney for continuous variables; chi-square test for categorical variables.

b

Manual occupation: skilled or partially skilled manual workers during pregnancy or most recent job before pregnancy.

OCs and rapid growth among normal-weight versus overweight mothers

HCB and βHCH were highly correlated (Spearman’s r = 0.79, log-transformed variables), with more moderate correlations with DDE (HCB–DDE, r = 0.29; βHCH–DDE, r = 0.39; PCBs–DDE, r = 0.39) and PCBs (PCBs–HCB, r = 0.51; PCBs–βHCH, r = 0.40). Overall, mean levels of all OCs were similar among rapid and average/slow growers (Table 2). However, among infants of women of normal prepregnancy weight, mean levels of DDE, HCB, and βHCH were significantly higher among rapid growers than among average/slow growers (p < 0.05). Neither the sum of PCBs nor individual PCBs (data not shown) were associated with rapid growth. In contrast, among infants of women overweight before pregnancy, mean OC levels were lower among rapid growers than among average/slow growers, although differences were not statistically significant.

Table 2.

Lipid-adjusted OC levels in first-trimester maternal serum for rapid and average/slow growers [geometric mean (95% (CI)].

OC Percent < LODa Average/slow growers Rapid growers
All infants, ng/g lipid (n = 518)

 DDE 0.0 125.40 (115.03–136.70) 135.59 (119.48–153.87)
 HCB 8.5 23.38 (19.00–28.78) 26.53 (18.47–38.13)
 βHCH 10.0 17.79 (14.37–22.04) 20.46 (13.98–29.94)
PCBs 7.7 43.72 (36.36–52.56) 47.99 (34.84–66.11)

Normal-weight mothers, ng/g lipid (n = 374)

 DDE* 0.0 120.76 (108.70–134.15) 146.78 (127.97–168.35)
 HCB* 9.1 18.82 (14.51–24.42) 31.21 (21.89–44.50)
 βHCH* 10.4 15.09 (11.57–19.70) 25.54 (17.55–37.19)
PCBs 7.2 45.20 (36.02–56.73) 66.96 (51.20–87.58)

Overweight mothers, ng/g lipid (n = 144)

 DDE 0.0 137.84 (118.71–160.07) 107.68 (80.46–144.10)
 HCB 6.9 40.28 (29.64–54.74) 16.56 (6.11–44.89)
 βHCH 9.0 26.89 (19.20–37.66) 10.73 (3.85–29.86)
PCBs 9.0 40.21 (29.50–54.80) 18.22 (7.14–46.51)

PCBs refers to sum of congeners 118, 138, 153, and 180. Among normal-weight mothers, n = 93 rapid growers (24.9%); among overweight mothers, n = 32 rapid growers (22.2%). All subjects had detectable levels of DDE.

a

LOD = 0.071 ng/mL serum for all OCs; values below this level set to LOD/2.

*

Wilcoxon–Mann–Whitney p-value < 0.05.

Among infants whose mothers were of normal prepregnancy weight, associations between increasing prenatal DDE exposure and rapid growth were nonlinear, with an increasing predicted risk followed by an apparent decline in the top 3% of exposure [> 750 ng/g; ~ 6.6 ng/g on the log scale; see Supplemental Material, Figure 1 (doi:10.1289/ehp.1002169)]. Therefore, OC exposures were categorized as quartiles to examine dose–response relationships between OCs and rapid growth (Table 3). Except for PCBs (data not shown), which were essentially unrelated to rapid growth (21.3%/25.2% rapid growers in the top/bottom quartile), risk of rapid growth among infants of normal-weight mothers rose with increasing quartiles of exposure to each OC. Disparities in rapid growth in this group were greatest for DDE, with a nearly 3 times greater frequency (29.8% vs. 11.7%; p < 0.05) in the highest than in the lowest quartiles. After multivariable adjustment, exposures above the lowest quartile of DDE were associated with a 2.4 times greater risk of rapid growth among normal-weight mothers (p < 0.05). Associations were similar and remained significant after adjusting for other OCs. For HCB and βHCH, however, associations with rapid growth were weakened and not significant after adjusting for DDE (Table 3). Because HCB and βHCH were highly correlated, we examined results adjusting for either OC but not both simultaneously; findings were very similar (data not shown).

Table 3.

Maternal OC levels and risk of rapid infant weight gain: number of rapid growers in each exposure group.

OC quartile Normal-prepregnancy-weight mothers (n = 374)
Overweight/obese mothers (n = 144)
Multivariable adjusted
Plus all OCsa [RR (95% CI)] Multivariable adjusted
Plus all OCsa [RR (95% CI)]
n (%) RR (95% CI) n (%) RR (95% CI)
DDE (ng/g lipid)

 ≤ 71.71 11 (11.7) 1.00 1.00 14 (38.9) 1.00 1.00
 71.71–116.92 27 (28.7) 2.42 (1.25–4.67) 2.21 (1.14–4.29) 5 (14.3) 0.48 (0.19–1.23) 0.61 (0.22–1.69)
 116.92–186.17 27 (29.3) 2.47 (1.24–4.92) 2.21 (1.07–4.54) 8 (21.1) 0.66 (0.29–1.54) 0.87 (0.41–1.87)
 > 186.17 28 (29.8) 2.47 (1.22–5.00) 2.16 (1.05–4.45) 5 (14.3) 0.43 (0.18–1.06) 0.43 (0.15–1.24)

HCB (ng/g lipid)

 ≤ 22.84 20 (18.0) 1.00 1.00 8 (42.1) 1.00 1.00
 22.84–41.00 20 (21.7) 1.17 (0.66–2.08) 0.92 (0.50–1.69) 10 (27.0) 0.46 (0.21–0.99) 0.17 (0.07–0.45)
 41.00–66.28 26 (28.0) 1.54 (0.90–2.64) 1.14 (0.60–2.17) 5 (13.5) 0.21 (0.08–0.52) 0.10 (0.03–0.35)
 > 66.28 27 (34.6) 1.78 (0.96–3.32) 1.20 (0.56–2.56) 9 (17.6) 0.19 (0.07–0.57) 0.11 (0.03–0.51)

βHCH (ng/g lipid)

 ≤ 21.70 16 (15.8) 1.00 1.00 8 (27.6) 1.00 1.00
 21.70–32.23 25 (25.0) 1.67 (0.95–2.93) 1.45 (0.81–2.62) 10 (34.5) 1.19 (0.48–2.96) 3.88 (1.40–10.70)
 32.23–47.28 22 (24.7) 1.53 (0.83–2.85) 1.13 (0.54–2.36) 6 (14.6) 0.44 (0.16–1.18) 1.95 (0.60–6.36)
 > 47.28 30 (35.7) 2.08 (1.11–3.87) 1.42 (0.67–3.01) 8 (17.8) 0.52 (0.16–1.67) 2.02 (0.63–6.48)

Multivariable model adjusted for exact age at examination, gestational age, any breast-feeding at 6 months, firstborn child, maternal smoking during pregnancy, education, and maternal age at delivery.

a

Additionally adjusted for quartiles of the other two OCs shown.

In the group of infants with normal-weight mothers, risk of rapid growth associated with the top quartile of DDE exposure was slightly strengthened by excluding the subjects (n = 15) with DDE > 750 ng/g (6.6 ng/g, log scale), none of whom were rapid growers (RR, 2.76; 95% CI, 1.36–5.62). Alternatively, excluding foreign-born mothers (73.3% of subjects at this level of exposure) had little effect (fourth vs. first quartile: RR = 2.35; 95% CI, 1.15–5.01). Results were also consistent after excluding n = 28 SGA infants (RR = 2.65; 95% CI, 1.26–5.58), or n = 15 low-birth-weight infants (RR = 3.04; 95% CI, 1.45–6.35). Using log DDE as a continuous measure, the RR per one-unit increase (2.72 ng/g on the original scale) was 1.24 (95% CI, 1.02–1.50) for all subjects and was 1.60 (95% CI, 1.22–2.09) after excluding the top 3% of exposure. Compared with infants of normal-weight mothers, infants in the smaller sample with overweight mothers showed associations that were inverse but not significant.

To maximize cell sizes in models stratified by maternal overweight, we used tertiles to explore whether associations between OCs and rapid growth varied by infant sex. Although DDE–child sex interaction terms did not achieve statistical significance (p = 0.17 overall; p = 0.14 among normal-weight mothers), DDE was more strongly associated with rapid growth in boys than in girls. Among boys with normal-weight mothers, the risk of rapid growth in the intermediate and highest tertiles of DDE was more than three times higher than in the lowest tertile (highest vs. lowest tertile: multivariable-adjusted RR = 3.61; 95% CI, 1.36–9.56; n = 6 rapid growers in the referent group). The intermediate (RR = 1.71; 95% CI, 0.90–3.23) but not the highest (RR = 0.90; 95% CI, 0.40–2.08) tertile of DDE was positively, although not significantly, associated with rapid growth in girls (n = 13 rapid growers in the referent group).

OCs, rapid growth, and BMI at 14 months

At 14 months, 13.9% of infants had elevated BMI z-scores. Rapid growers were more likely than were average/slow growers to have an elevated BMI z-score (35.5% vs. 7.1%; p < 0.05). After multivariable adjustment, rapid growth in the first 6 months was associated with a 5 times higher risk of elevated 14-month BMI, with similar associations among normal-weight and overweight mothers. In addition, prenatal DDE, but not other OCs, was associated with elevated BMI z-scores at 14 months among infants of normal-weight mothers (Table 4).

Table 4.

Associations for rapid early growth, maternal OC levels, and elevated BMI z-score (≥ 1.44) at 14 months [RR (95% CI)].

Variable All mothers (n = 502) Normal-prepregnancy-weight mothers (n = 365) Overweight/obese mothers (n = 137) Interaction p-value (× maternal weight status)
Multivariable models

 DDE (per log ng/g lipid) 1.22 (0.96–1.55) 1.64 (1.24–2.18) 0.93 (0.60–1.45) 0.086
 HCB (per log ng/g lipid) 0.97 (0.86–1.10) 1.02 (0.88–1.18) 0.74 (0.63–0.87) 0.680
 βHCH (per log ng/g lipid) 1.03 (0.93–1.15) 1.06 (0.90–1.23) 0.97 (0.84–1.12) 0.678
 Rapid growth in the first 6 months 4.71 (3.02–7.35) 5.18 (2.92–9.18) 5.02 (2.56–9.85) 0.420

Mutually adjusted contaminants

 DDE (per log ng/g lipid) 1.40 (1.12–1.75) 1.50 (1.11–2.03) 1.22 (0.81–1.84) 0.270
 HCB (per log ng/g lipid) 1.00 (0.85–1.17) 0.99 (0.85–1.15) 0.91 (0.74–1.12) 0.340
 βHCH (per log ng/g lipid) 0.96 (0.81–1.12) 0.92 (0.78–1.09) 0.95 (0.76–1.18) 0.601
 Rapid growth in the first 6 months 4.85 (3.12–7.54) 5.41 (2.88–10.15) 4.40 (2.09–9.28) 0.592

Data are multivariable-adjusted RRs (95% CIs) for likelihood of having an elevated BMI z-score at 14 months. All models adjusted for exact age at examination, maternal country of birth, maternal age at delivery, smoking during pregnancy, and parental overweight; rapid growth was included in all models along with either individual or multiple contaminants, as indicated.

Discussion

There is growing awareness that factors aside from increasing intakes of energy-dense foods and declining physical activity may play key roles in the obesity epidemic (McAllister et al. 2009). It is also increasingly apparent that long-term obesity risk may be evident from rapid growth initiated in the first months of life (Ong and Loos 2006). In this study, we found that among mothers not overweight or obese before pregnancy, higher DDE levels in first-trimester serum were strongly associated with two indicators of early obesity risk in their children: rapid weight gain in the first 6 months of life and elevated BMI z-scores at 14 months. These results are consistent with two earlier studies that reported associations between prenatal DDE exposure and obesity later in life (Karmaus et al. 2009; Verhulst et al. 2009). However, this analysis suggests, to our knowledge for the first time, that fetal DDE exposure may promote rapid growth starting in the immediate postnatal period, consistent with the hypothesis that early-life exposure to EDCs may promote obesogenic changes in metabolism (Heindel and vom Saal 2009).

Regardless of DDE exposure levels and maternal prepregnancy weight status, children with rapid growth in the first months of life had a 5 times higher risk of attaining BMIs exceeding the 85th percentile by 14 months of age. Although changes in feeding and other care practices could influence future growth trajectories in these children (Karaolis-Danckert et al. 2006), numerous studies suggest heavier weight status at 1–2 years is predictive of later obesity (Baird et al. 2005).

The “environmental obesogen” hypothesis postulates that the developmental period is a vulnerable window during which transient environmental exposures may alter the regulation of weight or adiposity over the long term, perhaps as a consequence of epigenetic changes influencing gene expression or protein regulation (Heindel and vom Saal 2009; Lee et al. 2009). In vitro and animal experiments suggest that some EDCs may upregulate adipogenesis or promote fat storage through mechanisms such as the activation of retinoid-X receptor, peroxisome proliferator activated receptor-γ, or glucocorticoid receptor pathways or by disruption of estrogen receptor signaling (Grün and Blumberg 2009; Sargis et al. 2010). The issue is of concern because exposure to many EDCs is widespread, as a result of long half-lives and extensive use in agriculture and industry (Lang et al. 2008; Wilson et al. 2003). Despite evidence of obesogenicity for a few chemicals in animal studies, however, few empirical data have linked such exposures to obesity in humans. In cross-sectional studies, higher levels of EDCs such as BPA and phthalates have been reported in obese than in normal-weight subjects, although because these EDCs are fat soluble, it is not clear whether this partly reflects larger adipose tissue depots in fatter subjects (Lang et al. 2008; Stahlhut et al. 2007).

DDE, a metabolite of the pesticide DDT, has not been explored in animal studies on environmental obesogens. However, experimental data indicate that DDE does modulate endocrine function and influences gene expression after binding to nuclear receptors (Li et al. 2008; Sonnenschein and Soto 1998). Although DDT use is prohibited in most industrialized countries, including Spain, high concentrations of DDE continue to be reported in human biomarker studies because of its long half-life and persistence in water, sediments, and the food chain. DDE levels in this sample were similar to those reported both among pregnant women by Verhulst et al. (2009) and in first-trimester samples in the U.S. National Health and Nutrition Examination Survey (Wang et al. 2009).

Other than DDE, the OCs examined in this study were not independently associated with either rapid early weight gain or BMI at 14 months. For PCBs, the absence of association is consistent with data from Karmaus et al. (2009), although Verhulst et al. (2009) reported a very small increase in BMI z-scores associated with PCB exposure (0.003 for each 1-ng/g increase). Verhulst et al. (2009) reported HCB exposure in a range similar to those in our sample to be unassociated with BMI through 3 years of age. Prenatal HCB levels here were three times lower than in a previous study (Smink et al. 2008) reporting an association with later childhood obesity (median, 0.25 vs. 0.68 ng/mL). Further research is needed to ascertain whether disparities in exposure levels or different mechanisms of action for either individual OCs or mixtures might explain why we observed significant positive associations only for DDE.

Excluding SGA or low-birth-weight infants had little influence; indeed, results were slightly strengthened after excluding either group. This is important given that rapid early growth was initially thought to increase obesity risk predominantly in SGA infants, who might be programmed in utero to use dietary energy efficiently, perhaps increasing susceptibility to excess weight gain when exposed to energy-dense foods and sedentary environments (Dunger and Ong 2005). It is now evident, however, that rapid early weight gain is linked with obesity among infants of average size (Karaolis-Danckert et al. 2006; Leunissen et al. 2009).

None of the small number of infants at the very highest levels of maternal DDE exposure (> 750 ng/g), primarily of foreign-born mothers, experienced rapid growth in the first 6 months. We cannot determine whether this occurred by chance, or whether very highly exposed children might be at reduced risk of rapid weight gain. However, similar opposing patterns of risk at low versus high exposure levels have been reported in other studies on health effects of xenoestrogens (Wadia et al. 2007; Weltje et al. 2005). Reasons for the differential associations between fetal DDE exposure and rapid growth by maternal prepregnancy weight status are also uncertain; although the sample was small, associations between DDE and early rapid growth appeared to be negative among overweight mothers. In our study, children of obese mothers were at increased risk of overweight for reasons independent of chemical exposures: these infants had higher weight and BMI z-scores at birth and at 6 and 14 months of age regardless of prenatal DDE levels (data not shown). Experimental evidence suggests that offspring of obese mothers may be at increased risk of obesity, possibly due to genetic susceptibility or perhaps to epigenetic changes (Waterland et al. 2008; Wu and Suzuki 2006). For example, lower intakes of nutrients such as folate, which has been reported among obese pregnant women (Rifas-Shiman et al. 2009), may increase risk of offspring obesity, given animal studies showing dietary supplementation with methyl donors including folate to be associated with reduced body weight in subsequent generations (Waterland et al. 2008). Animal studies have also reported stronger obesogenic effects of high-fat diets in offspring of obese than of normal-weight mothers (White et al. 2009). Moreover, observational studies have reported breast-feeding to be more strongly protective against child obesity among overweight mothers than among normal-weight mothers (Li et al. 2005). Very early growth patterns among infants of overweight and obese mothers may, therefore, be more strongly related to factors other than OC exposure.

Although interactions with child sex did not reach significance either overall or after stratifying by maternal weight status (p > 0.10), associations between DDE and rapid growth were stronger in boys. Some studies have suggested that effects of periconceptional exposures to EDCs and other factors may be sex-specific (Gabory et al. 2009; Tobi et al. 2009). The modest sample size may have lacked power to detect statistically significant interactions.

Although prenatal DDE exposure was associated with rapid weight gain and BMI, no direct measures of adiposity were available. However, previous studies have reported that rapid weight gain was more strongly associated with direct measures of body fatness than with BMI (Holzhauer et al. 2009; Karaolis-Danckert et al. 2006). We measured prenatal DDE only in maternal serum collected in early pregnancy; levels have been observed to increase later in pregnancy because of metabolic changes during gestation (Torres-Sánchez et al. 2007; Wang et al. 2009). However, studies using repeated measures from multiple trimesters have found that only first-trimester DDE was associated with early neurodevelopment and genital structure alterations (Torres-Sánchez et al. 2007, 2008). Although potential mechanisms are uncertain, associations with first-trimester measures are consistent with hypotheses involving epigenetic changes, because such effects have been observed to be more frequent for periconceptional than for later exposures (Lee et al. 2009; Tobi et al. 2009). Other limitations include the modest sample size, resulting in few rapid growers in the referent group and fairly wide conference intervals. An important strength is the large number of potential confounders considered, including birth weight and weight gain in pregnancy, which were only weakly (Spearman’s r < 0.10) correlated with prenatal DDE and did not confound associations. Although follow-up thus far is short, future analyses will assess longer-term effects of OCs on postnatal growth.

Conclusion

We found that among normal-weight mothers, prenatal DDE exposure was associated with an increased risk of rapid growth in the first 6 months of life, as well as elevated BMI at 14 months. Other OCs examined were not associated with increased risk of rapid growth. Given the large body of evidence indicating that rapid weight gain in the first months of life increases long-term risk of obesity and metabolic disorders, these data provide support for a possible role of prenatal exposure to DDE in programming these health problems. Future research is needed to assess whether the association may be causal and what the underlying mechanisms might be.

Footnotes

Supplemental Material is available online (doi:10.1289/ehp.1002169 via http://dx.doi.org/).

We acknowledge the study participants for their generous collaboration. We are also grateful to A. Sànchez, M. López, and N. Pey for their assistance in contacting the families and administering the questionnaires and to X. Basagaña for statistical advice.

This work was supported by grants from the Spanish Ministry of Health (FIS-PI041436), Instituto de Salud Carlos III (Red INMA G03/176 and CB06/02/0041), the Generalitat de Catalunya-CIRIT (Consejo Interdepartamental de Investigación e Innovación Tecnológica) (1999SGR 00241), and the Fundació Roger Torner.

A full roster of the Infancia y Medio-Ambiente–Sabadell Study investigators can be found at http://www.proyectoinma.org/cohorts/sabadell/en_membres-sabadell.html.

References

  1. Akaboshi I, Haraguchi Y, Mizumoto Y, Kitano A, Kan H. Taller stature after postnatal rapid weight gain in early infancy predicts overweight status at age 3. Acta Paediatr. 2008;97(10):1460–1464. doi: 10.1111/j.1651-2227.2008.00932.x. [DOI] [PubMed] [Google Scholar]
  2. Baird J, Fisher D, Lucas P, Kleijnen J, Roberts H, Law C. Being big or growing fast: systematic review of size and growth in infancy and later obesity. BMJ. 2005;331(7522):929. doi: 10.1136/bmj.38586.411273.E0. [Online 14 October 2005] [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blair NJ, Thompson JM, Black PN, Becroft DM, Clark PM, Han DY, et al. Risk factors for obesity in 7-year-old European children: the Auckland Birthweight Collaborative Study. Arch Dis Child. 2007;92(10):866–871. doi: 10.1136/adc.2007.116855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Botton J, Heude B, Maccario J, Ducimetière P, Charles MA. Postnatal weight and height growth velocities at different ages between birth and 5 y and body composition in adolescent boys and girls. Am J Clin Nutr. 2008;87(6):1760–1768. doi: 10.1093/ajcn/87.6.1760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buyken AE, Karaolis-Danckert N, Remer T, Bolzenius K, Landsberg B, Kroke A. Effects of breastfeeding on trajectories of body fat and BMI throughout childhood. Obesity (Silver Spring) 2008;16(2):389–395. doi: 10.1038/oby.2007.57. [DOI] [PubMed] [Google Scholar]
  6. Carrascosa A, Yeste D, Copil A, Almar J, Salcedo S, Gussinye M. Anthropometric growth patterns of preterm and full-term newborns (24–42 weeks’ gestational age) at the Hospital Materno-Infantil Vall d’Hebron (Barcelona) (1997–2002 [in Spanish] An Pediatr (Barc) 2004;60(5):406–416. doi: 10.1016/s1695-4033(04)78299-5. [DOI] [PubMed] [Google Scholar]
  7. Chomtho S, Wells JC, Davies PS, Lucas A, Fewtrell MS. Early growth and body composition in infancy. Adv Exp Med Biol. 2009;646:165–168. doi: 10.1007/978-1-4020-9173-5_19. [DOI] [PubMed] [Google Scholar]
  8. Cournil A, Coly AN, Diallo A, Simondon KB. Enhanced post-natal growth is associated with elevated blood pressure in young Senegalese adults. Int J Epidemiol. 2009;38(5):1401–1410. doi: 10.1093/ije/dyp255. [DOI] [PubMed] [Google Scholar]
  9. Demerath EW, Reed D, Choh AC, Soloway L, Lee M, Czerwinski SA, et al. Rapid postnatal weight gain and visceral adiposity in adulthood: the Fels Longitudinal Study. Obesity (Silver Spring) 2009;17(11):2060–2066. doi: 10.1038/oby.2009.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. de Onis M, Garza C, Onyango AW, Rolland-Cachera MF. WHO growth standards for infants and young children [in French] Arch Pediatr. 2009;16(1):47–53. doi: 10.1016/j.arcped.2008.10.010. [DOI] [PubMed] [Google Scholar]
  11. Dubois L, Girard M. Early determinants of overweight at 4.5 years in a population-based longitudinal study. Int J Obes (Lond) 2006;30(4):610–617. doi: 10.1038/sj.ijo.0803141. [DOI] [PubMed] [Google Scholar]
  12. Dunger DB, Ong KK. Endocrine and metabolic consequences of intrauterine growth retardation. Endocrinol Metab Clin North Am. 2005;34(3):597–615. ix. doi: 10.1016/j.ecl.2005.04.011. [DOI] [PubMed] [Google Scholar]
  13. Durmuş B, Mook-Kanamori DO, Holzhauer S, Hofman A, van der Beek EM, Boehm G, et al. Growth in foetal life and infancy is associated with abdominal adiposity at the age of 2 years: the generation R study. Clin Endocrinol (Oxf) 2010;72(5):633–640. doi: 10.1111/j.1365-2265.2009.03708.x. [DOI] [PubMed] [Google Scholar]
  14. Ekelund U, Ong K, Linne Y, Neovius M, Brage S, Dunger DB, et al. Upward weight percentile crossing in infancy and early childhood independently predicts fat mass in young adults: the Stockholm Weight Development Study (SWEDES) Am J Clin Nutr. 2006;83(2):324–330. doi: 10.1093/ajcn/83.2.324. [DOI] [PubMed] [Google Scholar]
  15. Elobeid MA, Allison DB. Putative environmental-endocrine disruptors and obesity: a review. Curr Opin Endocrinol Diabetes Obes. 2008;15(5):403–408. doi: 10.1097/MED.0b013e32830ce95c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Eriksson M, Tynelius P, Rasmussen F. Associations of birthweight and infant growth with body composition at age 15—the COMPASS study. Paediatr Perinat Epidemiol. 2008;22(4):379–388. doi: 10.1111/j.1365-3016.2008.00944.x. [DOI] [PubMed] [Google Scholar]
  17. EURODIAB Substudy 2 Study Group. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care. 2002;25(10):1755–1760. doi: 10.2337/diacare.25.10.1755. [DOI] [PubMed] [Google Scholar]
  18. Gabory A, Attig L, Junien C. Sexual dimorphism in environmental epigenetic programming. Mol Cell Endocrinol. 2009;304(1–2):8–18. doi: 10.1016/j.mce.2009.02.015. [DOI] [PubMed] [Google Scholar]
  19. Goñi F, Lopez R, Etxeandia A, Millan E, Amiano P. High throughput method for the determination of organochlorine pesticides and polychlorinated biphenyls in human serum. J Chromatogr B Anal Technol Biomed Life Sci. 2007;852(1–2):15–21. doi: 10.1016/j.jchromb.2006.12.049. [DOI] [PubMed] [Google Scholar]
  20. Goodell LS, Wakefield DB, Ferris AM. Rapid weight gain during the first year of life predicts obesity in 2–3 year olds from a low-income, minority population. J Community Health. 2009;34(5):370–375. doi: 10.1007/s10900-009-9164-6. [DOI] [PubMed] [Google Scholar]
  21. Grün F, Blumberg B. Endocrine disrupters as obesogens. Mol Cell Endocrinol. 2009;304(1–2):19–29. doi: 10.1016/j.mce.2009.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, et al. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol. 2006;20(9):2141–2155. doi: 10.1210/me.2005-0367. [DOI] [PubMed] [Google Scholar]
  23. Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol. 2009;169(12):1428–1436. doi: 10.1093/aje/kwp065. [DOI] [PubMed] [Google Scholar]
  24. Hastie T, Tibshirani R. Generalized additive models for medical research. Stat Methods Med Res. 1995;4(3):187–196. doi: 10.1177/096228029500400302. [DOI] [PubMed] [Google Scholar]
  25. Heindel JJ, vom Saal FS. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol Cell Endocrinol. 2009;304(1–2):90–96. doi: 10.1016/j.mce.2009.02.025. [DOI] [PubMed] [Google Scholar]
  26. Hitze B, Bosy-Westphal A, Plachta-Danielzik S, Bielfeldt F, Hermanussen M, Muller MJ. Long-term effects of rapid weight gain in children, adolescents and young adults with appropriate birth weight for gestational age: the Kiel Obesity Prevention Study. Acta Paediatr. 2010;99(2):256–262. doi: 10.1111/j.1651-2227.2009.01573.x. [DOI] [PubMed] [Google Scholar]
  27. Holzhauer S, Hokken Koelega AC, Ridder M, Hofman A, Moll HA, Steegers EA, et al. Effect of birth weight and postnatal weight gain on body composition in early infancy: the Generation R Study. Early Hum Dev. 2009;85(5):285–290. doi: 10.1016/j.earlhumdev.2008.11.002. [DOI] [PubMed] [Google Scholar]
  28. Huxley RR, Shiell AW, Law CM. The role of size at birth and postnatal catch-up growth in determining systolic blood pressure: a systematic review of the literature. J Hypertens. 2000;18(7):815–831. doi: 10.1097/00004872-200018070-00002. [DOI] [PubMed] [Google Scholar]
  29. Institute of Medicine. Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC: National Academies Press; 2009. [[accessed 1 June 2010]]. Available: http://www.iom.edu/Reports/2009/Weight-Gain-During-Pregnancy-Reexamining-the-Guidelines.aspx. [PubMed] [Google Scholar]
  30. Instituto Nacional de Estadística. Clasificación Nacional de Ocupaciones (CNO-94) 1994. [[accessed 12 January 2011]]. Available: http://www.ine.es/clasifi/cno94.xls.
  31. Jakszyn P, Goñi F, Etxeandia A, Vives A, Millán E, López R, et al. Serum levels of organochlorine pesticides in healthy adults from five regions of Spain. Chemosphere. 2009;76(11):1518–1524. doi: 10.1016/j.chemosphere.2009.05.048. [DOI] [PubMed] [Google Scholar]
  32. Kain J, Corvalán C, Lera L, Galvan M, Uauy R. Accelerated growth in early life and obesity in preschool Chilean children. Obesity (Silver Spring) 2009;17(8):1603–1608. doi: 10.1038/oby.2009.37. [DOI] [PubMed] [Google Scholar]
  33. Karaolis-Danckert N, Buyken AE, Bolzenius K, Perim de Faria C, Lentze MJ, Kroke A. Rapid growth among term children whose birth weight was appropriate for gestational age has a longer lasting effect on body fat percentage than on body mass index. Am J Clin Nutr. 2006;84(6):1449–1455. doi: 10.1093/ajcn/84.6.1449. [DOI] [PubMed] [Google Scholar]
  34. Karmaus W, Osuch JR, Eneli I, Mudd LM, Zhang J, Mikucki D, et al. Maternal levels of dichlorodiphenyl-dichloroethylene (DDE) may increase weight and body mass index in adult female offspring. Occup Environ Med. 2009;66(3):143–149. doi: 10.1136/oem.2008.041921. [DOI] [PubMed] [Google Scholar]
  35. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008;32(9):1431–1437. doi: 10.1038/ijo.2008.102. [DOI] [PubMed] [Google Scholar]
  36. Koletzko B, von Kries R, Closa R, Escribano J, Scaglioni S, Giovannini M, et al. Lower protein in infant formula is associated with lower weight up to age 2 y: a randomized clinical trial. Am J Clin Nutr. 2009;89(6):1836–1845. doi: 10.3945/ajcn.2008.27091. [DOI] [PubMed] [Google Scholar]
  37. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 2002;246:1–190. [PubMed] [Google Scholar]
  38. Lamb MM, Dabelea D, Yin X, Ogden LG, Klingensmith GJ, Rewers M, et al. Early-life predictors of higher body mass index in healthy children. Ann Nutr Metab. 2010;56(1):16–22. doi: 10.1159/000261899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lang IA, Galloway TS, Scarlett A, Henley WE, Depledge M, Wallace RB, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA. 2008;300(11):1303–1310. doi: 10.1001/jama.300.11.1303. [DOI] [PubMed] [Google Scholar]
  40. Law CM, Shiell AW, Newsome CA, Syddall HE, Shinebourne EA, Fayers PM, et al. Fetal, infant, and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation. 2002;105(9):1088–1092. doi: 10.1161/hc0902.104677. [DOI] [PubMed] [Google Scholar]
  41. Lee DH, Jacobs DR, Jr, Porta M. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ Health Perspect. 2009;117:1799–1802. doi: 10.1289/ehp.0900741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Leunissen RW, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. JAMA. 2009;301(21):2234–2242. doi: 10.1001/jama.2009.761. [DOI] [PubMed] [Google Scholar]
  43. Li C, Kaur H, Choi WS, Huang TT, Lee RE, Ahluwalia JS. Additive interactions of maternal prepregnancy BMI and breast-feeding on childhood overweight. Obes Res. 2005;13(2):362–371. doi: 10.1038/oby.2005.48. [DOI] [PubMed] [Google Scholar]
  44. Li J, Li N, Ma M, Giesy JP, Wang Z. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides. Toxicol Lett. 2008;183(1–3):65–71. doi: 10.1016/j.toxlet.2008.10.002. [DOI] [PubMed] [Google Scholar]
  45. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics; 1988. [Google Scholar]
  46. McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr. 2009;49(10):868–913. doi: 10.1080/10408390903372599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Mendez MA, Torrent M, Ferrer C, Ribas-Fitó N, Sunyer J. Maternal smoking very early in pregnancy is related to child overweight at age 5–7 y. Am J Clin Nutr. 2008;87(6):1906–1913. doi: 10.1093/ajcn/87.6.1906. [DOI] [PubMed] [Google Scholar]
  48. Monteiro PO, Victora CG. Rapid growth in infancy and childhood and obesity in later life—a systematic review. Obes Rev. 2005;6(2):143–154. doi: 10.1111/j.1467-789X.2005.00183.x. [DOI] [PubMed] [Google Scholar]
  49. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis. Int J Obes (Lond) 2008;32(2):201–210. doi: 10.1038/sj.ijo.0803760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ong KK, Emmett P, Northstone K, Golding J, Rogers I, Ness AR, et al. Infancy weight gain predicts childhood body fat and age at menarche in girls. J Clin Endocrinol Metab. 2009;94(5):1527–1532. doi: 10.1210/jc.2008-2489. [DOI] [PubMed] [Google Scholar]
  51. Ong KK, Loos RJ. Rapid infancy weight gain and subsequent obesity: systematic reviews and hopeful suggestions. Acta Paediatr. 2006;95(8):904–908. doi: 10.1080/08035250600719754. [DOI] [PubMed] [Google Scholar]
  52. Phillips DL, Pirkle JL, Burse VW, Bernert JT, Jr, Henderson LO, Needham LL. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol. 1989;18(4):495–500. doi: 10.1007/BF01055015. [DOI] [PubMed] [Google Scholar]
  53. Regidor E, Martinez D, Calle ME, Astasio P, Ortega P, Dominguez V. Socioeconomic patterns in the use of public and private health services and equity in health care. BMC Health Serv Res. 2008;8:183. doi: 10.1186/1472-6963-8-183. [Online 14 September 2008] [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Ribas-Fitó N, Ramon R, Ballester F, Grimalt J, Marco A, Olea N, et al. Child health and the environment: the INMA Spanish Study. Paediatr Perinat Epidemiol. 2006;20(5):403–410. doi: 10.1111/j.1365-3016.2006.00745.x. [DOI] [PubMed] [Google Scholar]
  55. Rifas-Shiman SL, Rich-Edwards JW, Kleinman KP, Oken E, Gillman MW. Dietary quality during pregnancy varies by maternal characteristics in Project Viva: a US cohort. J Am Diet Assoc. 2009;109(6):1004–1011. doi: 10.1016/j.jada.2009.03.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Royston P. Calculation of unconditional and conditional reference intervals for foetal size and growth from longitudinal measurements. Stat Med. 1995;14(13):1417–1436. doi: 10.1002/sim.4780141303. [DOI] [PubMed] [Google Scholar]
  57. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect. 2001;109:675–680. doi: 10.1289/ehp.01109675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sargis RM, Johnson DN, Choudhury RA, Brady MJ. Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation. Obesity (Silver Spring) 2010;18(7):1283–1288. doi: 10.1038/oby.2009.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Smink A, Ribas-Fitó N, Garcia R, Torrent M, Mendez MA, Grimalt JO, et al. Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr. 2008;97(10):1465–1469. doi: 10.1111/j.1651-2227.2008.00937.x. [DOI] [PubMed] [Google Scholar]
  60. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S, et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect. 2009;117:1549–1555. doi: 10.1289/ehp.11342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol. 1998;65(1–6):143–150. doi: 10.1016/s0960-0760(98)00027-2. [DOI] [PubMed] [Google Scholar]
  62. Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115:876–882. doi: 10.1289/ehp.9882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Taveras EM, Rifas-Shiman SL, Belfort MB, Kleinman KP, Oken E, Gillman MW. Weight status in the first 6 months of life and obesity at 3 years of age. Pediatrics. 2009;123(4):1177–1183. doi: 10.1542/peds.2008-1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009;18(21):4046–4053. doi: 10.1093/hmg/ddp353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Torres-Sánchez L, Rothenberg SJ, Schnaas L, Cebrián ME, Osorio E, Del Carmen Hernández M, et al. In utero p,p′-DDE exposure and infant neurodevelopment: a perinatal cohort in Mexico. Environ Health Perspect. 2007;115:435–439. doi: 10.1289/ehp.9566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Torres-Sánchez L, Zepeda M, Cebrián ME, Belkind-Gerson J, Garcia-Hernández RM, Belkind-Valdovinos U, et al. Dichlorodiphenyldichloroethylene exposure during the first trimester of pregnancy alters the anal position in male infants. Ann NY Acad Sci. 2008;1140:155–162. doi: 10.1196/annals.1454.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Toschke AM, Grote V, Koletzko B, von Kries R. Identifying children at high risk for overweight at school entry by weight gain during the first 2 years. Arch Pediatr Adolesc Med. 2004;158(5):449–452. doi: 10.1001/archpedi.158.5.449. [DOI] [PubMed] [Google Scholar]
  68. Verhulst SL, Nelen V, Hond ED, Koppen G, Beunckens C, Vael C, et al. Intrauterine exposure to environmental pollutants and body mass index during the first 3 years of life. Environ Health Perspect. 2009;117:122–126. doi: 10.1289/ehp.0800003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Wadia PR, Vandenberg LN, Schaeberle CM, Rubin BS, Sonnenschein C, Soto AM. Perinatal bisphenol A exposure increases estrogen sensitivity of the mammary gland in diverse mouse strains. Environ Health Perspect. 2007;115:592–598. doi: 10.1289/ehp.9640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Wang RY, Jain RB, Wolkin AF, Rubin CH, Needham LL. Serum concentrations of selected persistent organic pollutants in a sample of pregnant females and changes in their concentrations during gestation. Environ Health Perspect. 2009;117:1244–1249. doi: 10.1289/ehp.0800105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11–25. doi: 10.1080/17477160600586747. [DOI] [PubMed] [Google Scholar]
  72. Waterland RA, Travisano M, Tahiliani KG, Rached MT, Mirza S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int J Obes (Lond) 2008;32(9):1373–1379. doi: 10.1038/ijo.2008.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Weltje L, vom Saal FS, Oehlmann J. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response. Hum Exp Toxicol. 2005;24(9):431–437. doi: 10.1191/0960327105ht551oa. [DOI] [PubMed] [Google Scholar]
  74. White CL, Purpera MN, Morrison CD. Maternal obesity is necessary for programming effect of high-fat diet on offspring. Am J Physiol Regul Integr Comp Physiol. 2009;296(5):R1464–R1472. doi: 10.1152/ajpregu.91015.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Wilson NK, Chuang JC, Lyu C, Menton R, Morgan MK. Aggregate exposures of nine preschool children to persistent organic pollutants at day care and at home. J Expo Anal Environ Epidemiol. 2003;13(3):187–202. doi: 10.1038/sj.jea.7500270. [DOI] [PubMed] [Google Scholar]
  76. Worobey J, Lopez MI, Hoffman DJ. Maternal behavior and infant weight gain in the first year. J Nutr Educ Behav. 2009;41(3):169–175. doi: 10.1016/j.jneb.2008.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Wu Q, Suzuki M. Parental obesity and overweight affect the body-fat accumulation in the offspring: the possible effect of a high-fat diet through epigenetic inheritance. Obes Rev. 2006;7(2):201–208. doi: 10.1111/j.1467-789X.2006.00232.x. [DOI] [PubMed] [Google Scholar]
  78. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–706. doi: 10.1093/aje/kwh090. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES